{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:33:53Z","timestamp":1786988033247,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejca.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T21:17:39Z","timestamp":1475529459000},"page":"38-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells"],"prefix":"10.1016","volume":"68","author":[{"given":"Yueliang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund T.S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2016.09.001_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejca.2015.11.012","article-title":"Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: hopes and realities","volume":"54","author":"Bournet","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2016.09.001_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2016.09.001_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2045-3701-1-42","article-title":"Partners in crime: the TGF\u03b2 and MAPK pathways in cancer progression","volume":"1","author":"Chapnick","year":"2011","journal-title":"Cell Biosci"},{"key":"10.1016\/j.ejca.2016.09.001_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.18632\/oncotarget.1775","article-title":"Ras and autophagy in cancer development and therapy","volume":"5","author":"Schmukler","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2016.09.001_bib5","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1158\/0008-5472.CAN-06-4287","article-title":"Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid)","volume":"67","author":"Blum","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2016.09.001_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4155\/fmc.11.121","article-title":"Inhibition of Ras for cancer treatment: the search continues","volume":"3","author":"Baines","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1016\/j.ejca.2016.09.001_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nchembio.1560","article-title":"Small-molecule modulation of Ras signaling","volume":"10","author":"Spiegel","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ejca.2016.09.001_bib8","doi-asserted-by":"crossref","first-page":"18678","DOI":"10.1074\/jbc.M801855200","article-title":"A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells","volume":"283","author":"Wang","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2016.09.001_bib9","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1038\/onc.2010.247","article-title":"Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2016.09.001_bib10","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/tx800220h","article-title":"Trapping of phenylacetaldehyde as a key mechanism responsible for naringenin's inhibitory activity in mutagenic 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine formation","volume":"21","author":"Cheng","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.ejca.2016.09.001_bib11","series-title":"Preventive potential and mechanism of dietary phenolics on the formation of mutagenic heterocyclic amines","author":"Cheng","year":"2009"},{"key":"10.1016\/j.ejca.2016.09.001_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ejca.2016.09.001_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejca.2016.09.001_bib14","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"Voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ejca.2016.09.001_bib15","first-page":"gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ejca.2016.09.001_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni.3154","article-title":"Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells","volume":"16","author":"Shi","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ejca.2016.09.001_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1091\/mbc.E02-07-0390","article-title":"Isoprenylcysteine carboxyl methyltransferase activity modulates endothelial cell apoptosis","volume":"14","author":"Kramer","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.ejca.2016.09.001_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2005.10.040","article-title":"A general liquid chromatography\/mass spectroscopy-based assay for detection and quantitation of methyltransferase activity","volume":"349","author":"Salyan","year":"2006","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ejca.2016.09.001_bib19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/SLA.0b013e318265bd6f","article-title":"Plasma miR-21: a potential diagnostic marker of colorectal cancer","volume":"256","author":"Kanaan","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2016.09.001_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4161\/auto.6.8.13614","article-title":"FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy","volume":"6","author":"Zhang","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.ejca.2016.09.001_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4161\/auto.6.2.11042","article-title":"Macroautophagy and ERK phosphorylation counteract the anti-proliferative effect of proteasome inhibitor in gastric cancer cells","volume":"6","author":"Wu","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.ejca.2016.09.001_bib22","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.ejca.2014.09.012","article-title":"Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine","volume":"50","author":"Cavaliere","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2016.09.001_bib23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ejca.2008.02.043","article-title":"Blocking on the CXCR4\/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells","volume":"44","author":"Hashimoto","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2016.09.001_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4161\/auto.2.2.2463","article-title":"Autophagy and cancer therapy","volume":"2","author":"Kondo","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.ejca.2016.09.001_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4161\/auto.4311","article-title":"Modulating autophagy for therapeutic benefit","volume":"3","author":"Carew","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.ejca.2016.09.001_bib26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4161\/auto.5921","article-title":"Autophagy: an emerging target for cancer therapy","volume":"4","author":"H\u00f8yer-Hansen","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.ejca.2016.09.001_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2016.09.001_bib28","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.2174\/092986712800229050","article-title":"Modulation of K-Ras signaling by natural products","volume":"19","author":"Bharate","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ejca.2016.09.001_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1535-7163.MCT-06-0706","article-title":"Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid)","volume":"6","author":"Zundelevich","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejca.2016.09.001_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.drup.2005.11.002","article-title":"Tailoring Ras-pathway-inhibitor combinations for cancer therapy","volume":"8","author":"Blum","year":"2005","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.ejca.2016.09.001_bib31","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1158\/1078-0432.CCR-04-2071","article-title":"Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest","volume":"11","author":"Yaari","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2016.09.001_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.18632\/oncotarget.703","article-title":"Ras inhibition enhances autophagy, which partially protects cells from death","volume":"4","author":"Schmukler","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2016.09.001_bib33","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2016.09.001_bib34","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/ijc.22144","article-title":"Raf kinases: oncogenesis and drug discovery","volume":"119","author":"Schreck","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2016.09.001_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1535-6108(03)00275-7","article-title":"Will mTOR inhibitors make it as cancer drugs?","volume":"4","author":"Sawyers","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2016.09.001_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2443.1999.00270.x","article-title":"Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action","volume":"4","author":"Morishima","year":"1999","journal-title":"Genes Cells"},{"key":"10.1016\/j.ejca.2016.09.001_bib37","first-page":"312","article-title":"CAAX-box protein, prenylation process and carcinogenesis","volume":"1","author":"Gao","year":"2009","journal-title":"Am J Transl Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916324017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916324017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T02:54:34Z","timestamp":1568429674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916324017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":37,"alternative-id":["S0959804916324017"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.09.001","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}